![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0036.png)
35
35
Diretrizes AMB
occlusive events in patients with ischemic stroke. JAMA 2004;291:576-
84.19.
19.Pengo V, Ruffatti A,Legnani C, Gresele P, Barcellona D, Erba N, et
al. Clinical course of high-risk patients diagnosed with
antiphospholipid syndrome. J Thromb Haemost 2010;8:237-42.
20. Lefèvre G, Lambert M, Bacri JL, Dubucquoi S, Quemeneur T,
Caron C, et al. Thrombotic events during long-term follow-up of
obstetric antiphospholipid syndrome patients. Lupus 2011;20:861-5.
21. Cervera R, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S,
Kiss E, et al. Morbidity and mortality in the antiphospholipid
syndrome during a 5-year period: a multicentre prospective study of
1000 patients. Ann Rheum Dis 2009;68:1428-32.
22.
Erkan D, Merrill JT, Yazici Y, Sammaritano L, Buyon JP, Lockshin
MD. High thrombosis rate after fetal loss in antiphospholipid
syndrome: effective prophylaxis with aspirin. Arthritis Rheum
2001;44:1466-7.
23..Gris JC, Bouvier S, Molinari N, Galanaud JP, Cochery-Nouvellon
E, Mercier E, et al. Comparative incidence of a first thrombotic event
in purely obstetric antiphospholipid syndrome with pregnancy loss:
the NOH-APS observational study. Blood 2012;119:2624-32.
24. Cowchock S, Reece EA. Do low-risk pregnant women with
antiphospholipid antibodies need to be treated? Organizing Group of
the Antiphospholipid Antibody Treatment Trial. Am J Obstet
Gynecol 1997;176:1099-100.
25. Bergrem A, Jacobsen EM, Skjeldestad FE, Jacobsen AF, Skogstad
M, Sandset PM. The association of antiphospholipid antibodies with
pregnancy-related first time venous thrombosis--a population-based
case-control study. Thromb Res 2010;125:e222-7.
26. Quenby S, Farquharson RG, Dawood F, Hughes AM, Topping J.
Recurrent miscarriage and long-term thrombosis risk: a case-control
study. Hum Reprod 2005;20:1729-32.
27. Martinez-Zamora MA, Peralta S, Creus M, Tassies D, Reverter JC,
Espinosa G, et al. Risk of thromboembolic events after recurrent
spontaneous abortion in antiphospholipid syndrome: a case-control
study. Ann Rheum Dis 2012;71:61-6.
28. Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM,
Vandvik PO, et al. VTE, thrombophilia, antithrombotic therapy, and
pregnancy: Antithrombotic Therapy and Prevention of Thrombosis,